Beta-lactam hypersensitivity in children: Frequency and risk factors

Haifa Ben Romdhane1, Nadia Ben Fredj1, Najah Ben Fadhel1

  • 1Department of Pharmacology, EPS Fattouma Bourguiba, Faculty of Medicine, University of Monastir, Tunisia.

Insights

Authentic beta-lactam (BL) hypersensitivity (HS) occurs in 6.7% of children. Older age and specific BLs administered are key predictors of BL hypersensitivity in pediatric patients.

Area of Science:

  • Pediatric Allergy and Immunology
  • Clinical Pharmacology
  • Immunology

Background:

  • Beta-lactam (BL) antibiotics are widely prescribed, but hypersensitivity (HS) reactions are a concern.
  • Accurate diagnosis of BL hypersensitivity is crucial to avoid unnecessary avoidance of essential medications.
  • Identifying predictive factors for BL hypersensitivity can aid in risk stratification and management.

Purpose of the Study:

  • To determine the frequency of authentic beta-lactam (BL) hypersensitivity (HS) in a large pediatric cohort.
  • To identify clinical risk factors that predict the development of BL hypersensitivity in children.

Main Methods:

  • Children with suspected BL allergy underwent skin testing (ST) and, if negative, a 1-day oral provocation test (OPT).
  • Authentic BL-HS was defined by positive ST or OPT results.
  • Univariate and multivariate logistic regression analyses were used to identify independent predictors of BL-HS.

Main Results:

  • Out of 354 patients, 24 (6.7%) were diagnosed with authentic BL-HS, all confirmed by positive ST.
  • Oral provocation tests were negative in all 30 children who underwent them.
  • Older age (>5 years) at reaction onset (OR=1.11) and the specific BL administered (OR=7.7) were significantly associated with authentic BL-HS.

Conclusions:

  • Beta-lactam hypersensitivity requires thorough allergy work-up before strict avoidance.
  • Patient age and the specific beta-lactam involved are valuable predictive factors for BL hypersensitivity in children.
  • These findings can guide clinical decisions and improve the management of suspected BL allergies in pediatric populations.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
128
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
120
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
97
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
144
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
120
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.1K